Anca Dana Buzoianu

Prof. Anca Dana Buzoianu

Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Cluj, Romania
orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 May 2017 in Cellular and Molecular Life Sciences
Verified
Journal Article
Closed access
PDF file
TMTeodora Mocan
Teodora Mocan
CMCristian T. Matea
Cristian T. Matea
TPTeodora Pop
Teodora Pop
OMOfelia Mosteanu
Ofelia Mosteanu
ABAnca Dana Buzoianu
Anca Dana Buzoianu
LMLucian Mocan
Lucian Mocan

31 March 2017 in Journal of Nanobiotechnology
Verified
Journal Article
Open access
PDF file
TMTeodora Mocan
Teodora Mocan
CMCristian-Tudor Matea
Cristian-Tudor Matea
TPTeodora Pop
Teodora Pop
OMOfelia Mosteanu
Ofelia Mosteanu
ABAnca Dana Buzoianu
Anca Dana Buzoianu
LMLucian Mocan
Lucian Mocan
Pathogenic bacteria contribute to various globally important diseases, killing millions of people each year. Various fields of medicine currently benefit from or may potentially benefit from the use of nanotechnology applications, in which there is growing interest. Disease-related biomarkers can be rapidly and directly detected by nanostructures, such as nanowires, nanotubes, nanoparticles, cantilevers, microarrays, and nanoarrays, as part of an accurate process characterized by lower sample consumption and considerably higher sensitivity. There is a need for accurate techniques for pathogenic bacteria identification and detection to allow the prevention and management of pathogenic diseases and to assure food safety. The focus of this review is on the current nanoparticle-based techniques for pathogenic bacterial identification and detection using these applications.

27 August 2013 in Phytochemical Analysis
Verified
Journal Article
Closed access
PDF file
Raluca Maria PopRaluca Maria Pop
Raluca Maria Pop
Carmen SocaciuCarmen Socaciu
Carmen Socaciu
Adela PinteaAdela Pintea
Adela Pintea
ABAnca Dana Buzoianu
Anca Dana Buzoianu
MSMark Gerardus Sanders
Mark Gerardus Sanders
JVJean‐Paul Vincken
Jean‐Paul Vincken

28 January 2022 in Biomedicines
Verified
Journal Article
Open access
PDF file
CCCristian-Ioan Craciun
Cristian-Ioan Craciun
MNMaria Adriana Neag
Maria Adriana Neag
ACAdrian Catinean
Adrian Catinean
MNMaria Neag
Maria Neag
ARAdriana Rusu
Adriana Rusu
ACAnca-Elena Craciun
Anca-Elena Craciun
Diabetes mellitus is considered to be a global epidemic. The combination of genetic susceptibility and an unhealthy lifestyle is considered to be the main trigger of this metabolic disorder. Recently, there has been increased interest in the roles of gut microbiota as a new potential contributor to this epidemic. Research, in recent years, has contributed to an in-depth characterization of the human microbiome and its associations with various diseases, including metabolic diseases and diabetes mellitus. It is known that diet can change the composition of gut microbiota, but it is unclear how this, in turn, may influence metabolism. The main objective of this review is to evaluate the pathogenetic association between microbiota and diabetes and to explore any new therapeutic agents, including nutraceuticals that may modulate the microbiota. We also look at several mechanisms involved in this process. There is a clear, bidirectional relationship between microbiota and diabetes. Current treatments for diabetes influence microbiota in various ways, some beneficial, but others with still unclear effects. Microbiota-aimed treatments have seen no real-world significant effects on the progression of diabetes and its complications, with more studies needed in order to find a really beneficial agent.

19 January 2017 in Human Resources for Health
Verified
Journal Article
Open access
PDF file
ȘSȘoimița Mihaela Suciu
Șoimița Mihaela Suciu
CPCodruța Popescu
Codruța Popescu
MCMugur Daniel Ciumageanu
Mugur Daniel Ciumageanu
ABAnca Dana Buzoianu
Anca Dana Buzoianu
Migration of healthcare workers is receiving increased attention worldwide. In Europe, the creation of a border-free labor market and its expansion with the EU enlargements of 2004, 2007, and 2013 endowed health professionals with the right to provide services and to relocate to another EU Member State. For the Romanian doctors, the EU-wide recognition of the medical degree obtained in Romania has created new opportunities, while inadequate working conditions and relatively low salaries pushed many of them to search for employment abroad. As there is considerable uncertainty about the magnitude of the Romanian physicians’ exodus, we performed a survey to assess the emigration intention of future Romanian doctors. The study was conducted over three consecutive years: 2013, 2014, and 2015 at the University of Medicine and Pharmacy “Iuliu Hatieganu” Cluj-Napoca, Romania. The self-administrated questionnaire included 19 questions regarding students’ emigration intentions. All the 957 license-degree students participated in the study. In this study, 84.7% of subjects planned on seeking employment abroad after graduation. A large number of the students who have participated in the study have already started preparing for emigration, 21.7% of those who wished to migrate had already performed at least one Erasmus mobility in their country of choice, 44.5% have been enrolled in a language course, and 42.7% have searched for jobs on the Internet. The majority of Romanian medical students considering migration see it as a serious alternative to the continuation of their professional training started in Romania. The findings of this study are upsetting and can impact both policy crafting and future research. Structural reforms in the healthcare provisions are needed in order to facilitate the retention of medical personnel. Romanian policy makers need to devise a comprehensive national health workforce plan to deal with physician migration.

20 September 2022 in Biomedicines
Verified
Journal Article
Open access
PDF file
Ioana Corina BocsanIoana Corina Bocsan
Ioana Corina Bocsan
DMDan Claudiu Măgureanu
Dan Claudiu Măgureanu
Raluca Maria PopRaluca Maria Pop
Raluca Maria Pop
ALAntonia-Mihaela Levai
Antonia-Mihaela Levai
SMStefan Octavian Macovei
Stefan Octavian Macovei
ABAnca Dana Buzoianu
Anca Dana Buzoianu
Grape pomace (GP) represents a very reliable source of polyphenols because it could be found globally as a remnant of the wine industry. During the winemaking process, two types of GP are generated: red GP and white GP, according to the produced wine, red or white. Grape pomace represents a viable source of polyphenols, mainly flavanols, procyanidins anthocyanins, and resveratrol which possess antioxidant and anti-inflammatory activities. Multiple differences were observed between red and white GP in terms of their antioxidant and anti-inflammatory activity in both in vitro and in vivo studies. Although most studies are focused on the antioxidant and anti-inflammatory effect of red grape pomace, there are still many variables that need to be taken into consideration, as well as extensive study of the white GP. It was observed that in both in vitro and in vivo studies, the GP polyphenols have a direct antioxidant activity by acting as a free radical scavenger or donating a hydrogen atom. It also possesses an indirect antioxidant and anti-inflammatory activity by reducing mitochondrial reactive oxygen species (ROS) generation, malondialdehyde (MDA), tumor necrosis factor-alpha (TNF-α), interleukin-1-beta (IL-1β), interleukin-6 (IL-6), nuclear factor kappa-light-chain-enhancer of activated B cells (NF- κβ), and inhibitor of nuclear factor kappa-B kinase subunit beta (Iκκβ) levels or nitrate oxide-4 (NOX4) expression and by increasing the levels of antioxidants enzymes like superoxide dismutase (SOD), catalase (CAT) glutathione reductase (GRx) and glutathione peroxidase(GPx). Besides these activities, many beneficial effects in ischemic heart diseases were also observed, such as the maintenance of the ventricular function as close as possible to normal, and the prevention of infarcted area extension. In this context, this review intends to present the actual knowledge of grape pomace’s potential antioxidant and anti-inflammatory activity in ischemic heart disease, knowledge gathered from existing in vitro and in vivo studies focused on this.